0Studies tracked
0Claims cite
0Videos use
Average study score: 71/100
Bibliography
Studies by this author
1 study attributed to Thomas U. Marron on the platform. Click a card to read the full analysis.
Study
Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1/2 trial
To assess safety, immunogenicity, and preliminary efficacy of a personalized DNA neoantigen vaccine (GNOS-PV02) encoding up to 40 neoantigens plus plasmid-encoded IL-12 and pembrolizumab in adults with advanced hepatocellular carcinoma previously treated with a multityrosine kinase inhibitor.